Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5698768 | Clinical Oncology | 2013 | 7 Pages |
Abstract
The addition of docetaxel to a cisplatin doublet ICT regimen before concurrent CRT may improve disease control for locally advanced HNSCC.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
M. Teo, E. Karakaya, C.A. Young, K.E. Dyker, C. Coyle, M. Sen, R.J.D. Prestwich,